Novo Nordisk’s $1.1 Billion Acquisition of Forma Therapeutics

Davis Polk advised Novo Nordisk on the deal while Goodwin Procter represented Forma Therapeutics.Novo Nordisk announced its approximately $1.1 billion acquisition of Forma Therapeutics. Under the terms…

This content is for members only.
Login to Read More Join Now
Laura Testa

Author: Laura Testa

This content is for members only.
Login to Read More Join Now